3-iodobenzylguanidine has been researched along with technetium tc 99m hydroxymethylene diphosphonate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bouvier, JF; Brunat Mentigny, M; Chauvot, P; Ducrettet, F; Lahneche, BE; Maïassi, N; Philip, T | 1 |
Delisle, MJ; Liehn, JC; Pérault, C; Schvartz, C; Wampach, H | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and technetium tc 99m hydroxymethylene diphosphonate
Article | Year |
---|---|
Pitfalls and solutions in neuroblastoma diagnosis using radioiodine MIBG: our experience about 50 cases.
Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Child; Child, Preschool; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Neoplasm Metastasis; Neuroblastoma; Technetium Tc 99m Medronate; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1988 |
Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Carcinoid Tumor; Carcinoma, Medullary; Feasibility Studies; Humans; Image Processing, Computer-Assisted; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Octreotide; Pentetic Acid; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Technetium Tc 99m Medronate; Thoracic Neoplasms; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1997 |